Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

PURPOSE: Dose escalation may improve curability in intermediate-risk prostate carcinoma. A multicenter national program was developed to assess toxicity and tumor response with hypofractionated stereotactic boost after conventional radiotherapy in intermediate-risk prostate cancer. METHODS AND MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, David, Nickers, Philippe, Peiffert, Didier, Maingon, Philippe, Pommier, Pascal, Lacornerie, Thomas, Martinage, Geoffrey, Tresch, Emmanuelle, Lartigau, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708754/
https://www.ncbi.nlm.nih.gov/pubmed/29190707
http://dx.doi.org/10.1371/journal.pone.0187794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708754/
https://www.ncbi.nlm.nih.gov/pubmed/29190707
http://dx.doi.org/10.1371/journal.pone.0187794

Ejemplares similares